ALLR

Conviction 41HealthcareScan · Thu, Jun 25, 2026

ALLR$1.28-1.92%

ResistanceSupportVol 14

Vol MA14 163.32K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Allarity Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.allarity.com ↗

Price1.28

Change-1.92%

Gap+0.77%

Rel volume0.52×

Avg volume178.1K

Avg $ vol272.72K

SMA 201.51

SMA 501.47

SMA 2001.29

Price vs 50-13.27%

Price vs 200-0.98%

MA stackmixed

50/200 cross—

Supertrendup · 1.27

RSI (14)39

MACD hist-0.04

MACD cross—

Stoch %K / %D6 / 8

ADX (14)26

+DI / −DI10 / 19

RSI divergenceBearish

MACD divergenceBearish

ATR %+10.39%

ADR %8.68%

52w high1.97

52w low0.8100

From 52w high-35.28%

Above 52w low+57.41%

New 52w highNo

SqueezeOff

Bollinger width37.17%

%B0.08

Donchian pos5.94%

Donchian high1.75

Donchian low1.25

AVWAP (52w high)1.68

vs AVWAP high-24.18%

AVWAP (52w low)1.31

vs AVWAP low-2.66%

OBV trendDown

Chaikin MF (20)-0.08

Today vs 20d0.52×

Avg vol (14d)163.32K

Avg vol (20d)178.1K

Avg $ vol (20d)272.72K

Market cap20.29M

RS 3m (vs SPY)+3.81%

RS 6m (vs SPY)+18.48%

RS line new highNo

Trend template3/8

Technical rank39.6

1 week-4.85%

1 month-24.33%

3 months+13.84%

6 months+30.10%

1 year+21.43%

YTD+11.84%

P/E-1.81

P/B2.93

P/S63.39

P/FCF-1.37

EPS-10.26

Div yield—

ROE-162.30%

ROA-32.16%

Debt/Eq0.42

Current1.23

EV/EBITDA-0.27

Gross margin-707.81%

Net margin—

Rev growth—

EPS growth54.19%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value3.41M

Revenue25K

Net income-2.75M

Gross profit-1.25M

Free cash flow-14.83M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out15.91M

Employees8

ListedTue, Dec 21, 2021

Free float15.79M

Float %99.8%

Short interest175.24K

Days to cover0.6d

Short volume28.9%

Squeeze score5 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction41 / 100

Pattern quality—

Tech rank39.6 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.79

Support1.26

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ALLR

All disclosures →

No recent disclosed trades by Congress in ALLR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ALLR · 3 buys

Insider	Side	Shares	Value	Traded	Filed
Jensen Thomas CEO · Common Stock · 2026-01-28	Grant	200K	$0	2026-01-28	2026-05-14
Hoeiland Jesper Director · Common Stock · 2026-01-07	Grant	25K	$0	2026-01-07	2026-05-11
McLaughlin Gerald W. Director · Common Stock · 2026-01-28	Grant	45K	$0	2026-01-28	2026-05-07

SEC filings

EDGAR filings in ALLR · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.